pre-diabetes or type 2 diabetes
Conditions
Interventions
pre-diabetes or T2DM:Jinqi Jiangtang Tablets (a drug approved by the state for marketing), oral, taken half an hour before meals, 2 tablets at a time, 3 times a day, 2 months a course of treatment
Sponsors
Beijing Friendship Hospital, Capital Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1) Conform to the diagnostic criteria of pre diabetes or type 2 diabetes; 2) Men and women aged = 18 years and = 75 years; 3) Willing to participate in and sign the informed consent form, able to understand and willing to comply with the requirements of the research program to complete the study.
Exclusion criteria
Exclusion criteria: 1) Complicated with serious primary diseases such as heart, cerebrovascular, liver, kidney and hematopoietic system; 2) Severe complications of diabetes; 3) Women who are pregnant or preparing for pregnancy and lactating women; 4) Psychosis, lack of insight or inability to express intention accurately; Or not in accordance with the author (those who do not cooperate with the diet or do not use drugs as required); 5) Those who have participated in other clinical researches within 4 weeks; 6) Patients who have received medical treatment for diabetes; 7) Allergic constitution; 8) Poor compliance; 9) Any other situation that the researcher thinks is not suitable for participating in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| HbA1c;FPG;2h PG; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total effective rate;INS;HOMA-IR;BMI;intestinal flora;Metabolomics of plasma;Plasma proteome;Serum lipid;Overall incidence of adverse events and individual incidence of adverse events;The laboratory checks for changes in parameters; | — |
Countries
China
Contacts
Public ContactYan Dan
Beijing Friendship Hospital, Capital Medical University
Outcome results
None listed